Cargando…
High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A hig...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103772/ https://www.ncbi.nlm.nih.gov/pubmed/34330502 http://dx.doi.org/10.1016/j.clnesp.2021.04.020 |
_version_ | 1783689365180907520 |
---|---|
author | Alcántara-Alonso, Estefanía Molinar-Ramos, Fernando González-López, Jesús Alberto Alcántara-Alonso, Viridiana Muñoz-Pérez, Marco Antonio Lozano-Nuevo, José Juan Benítez-Maldonado, Daniel Rabindranath Mendoza-Portillo, Elizabeth |
author_facet | Alcántara-Alonso, Estefanía Molinar-Ramos, Fernando González-López, Jesús Alberto Alcántara-Alonso, Viridiana Muñoz-Pérez, Marco Antonio Lozano-Nuevo, José Juan Benítez-Maldonado, Daniel Rabindranath Mendoza-Portillo, Elizabeth |
author_sort | Alcántara-Alonso, Estefanía |
collection | PubMed |
description | BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A high triglyceride to high density lipoprotein cholesterol (Tg/HDL c) ratio has been associated with reduced insulin sensitivity, metabolic syndrome and adverse cardiovascular events. Our aim in this study was to determine the association between different components of the lipid profile and particularly the Tg/HDL c ratio with severe complications like the requirement of invasive mechanical ventilation in COVID-19 patients. METHODS: We collected demographic, clinical and biochemical data to conduct a cohort study in 43 adult patients with confirmed COVID-19 diagnosis by quantitative polymerase chain reaction (qPCR) at baseline and in the subsequent 15 days. Patients were subjected to a very similar treatment scheme with the JAK1/2 inhibitor ruxolitinib. Descriptive statistics, variable association and logistic regression were applied to identify predictors of disease severity among elements and calculations from the lipid profile. RESULTS: Patients were aged 57 ± 14 years; 55.8% were male from which 75% required hospitalization and 44.2% were female who 58% were hospitalized. The most common comorbidities were type 2 diabetes mellitus (58%) and hypertension (40%). Hospitalized and critical care patients showed lower HDL c blood levels and increased Tg/HDL c ratio than those with outpatient management and mild/asymptomatic COVID-19. Tg/HDL c ratio correlated with variables of disease severity such as lactate dehydrogenase (LDH) levels (r = 0.356; p < 0.05); National Early Warning Score 2 (NEWS 2) (r = 0.495; p < 0.01); quick sequential organ failure assessment (qSOFA) (r = 0.538; p < 0.001); increased need of oxygen support (r = 0.447; p < 0.01) and requirement of mechanical ventilation (r = 0.378; p < 0.05). Tg/HDL c ratio had a negative correlation with partial oxygen saturation/fraction of inspired oxygen (SaO 2/FiO2) ratio (r = −0.332;p < 0.05). Linear regression analysis showed that Tg/HDL c ratio can predict increases in inflammatory factors like LDH (p < 0.01); ferritin (p < 0.01) and D-dimer (p < 0.001). Logistic regression model indicated that ≥7.45 Tg/HDL c ratio predicts requirement of invasive mechanical ventilation (OR 11.815, CI 1.832–76.186, p < 0.01). CONCLUSIONS: The Tg/HDLc ratio can be used as an early biochemical marker of COVID-19 severe prognosis with requirement of invasive mechanical ventilation. |
format | Online Article Text |
id | pubmed-8103772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81037722021-05-10 High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients Alcántara-Alonso, Estefanía Molinar-Ramos, Fernando González-López, Jesús Alberto Alcántara-Alonso, Viridiana Muñoz-Pérez, Marco Antonio Lozano-Nuevo, José Juan Benítez-Maldonado, Daniel Rabindranath Mendoza-Portillo, Elizabeth Clin Nutr ESPEN Original Article BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A high triglyceride to high density lipoprotein cholesterol (Tg/HDL c) ratio has been associated with reduced insulin sensitivity, metabolic syndrome and adverse cardiovascular events. Our aim in this study was to determine the association between different components of the lipid profile and particularly the Tg/HDL c ratio with severe complications like the requirement of invasive mechanical ventilation in COVID-19 patients. METHODS: We collected demographic, clinical and biochemical data to conduct a cohort study in 43 adult patients with confirmed COVID-19 diagnosis by quantitative polymerase chain reaction (qPCR) at baseline and in the subsequent 15 days. Patients were subjected to a very similar treatment scheme with the JAK1/2 inhibitor ruxolitinib. Descriptive statistics, variable association and logistic regression were applied to identify predictors of disease severity among elements and calculations from the lipid profile. RESULTS: Patients were aged 57 ± 14 years; 55.8% were male from which 75% required hospitalization and 44.2% were female who 58% were hospitalized. The most common comorbidities were type 2 diabetes mellitus (58%) and hypertension (40%). Hospitalized and critical care patients showed lower HDL c blood levels and increased Tg/HDL c ratio than those with outpatient management and mild/asymptomatic COVID-19. Tg/HDL c ratio correlated with variables of disease severity such as lactate dehydrogenase (LDH) levels (r = 0.356; p < 0.05); National Early Warning Score 2 (NEWS 2) (r = 0.495; p < 0.01); quick sequential organ failure assessment (qSOFA) (r = 0.538; p < 0.001); increased need of oxygen support (r = 0.447; p < 0.01) and requirement of mechanical ventilation (r = 0.378; p < 0.05). Tg/HDL c ratio had a negative correlation with partial oxygen saturation/fraction of inspired oxygen (SaO 2/FiO2) ratio (r = −0.332;p < 0.05). Linear regression analysis showed that Tg/HDL c ratio can predict increases in inflammatory factors like LDH (p < 0.01); ferritin (p < 0.01) and D-dimer (p < 0.001). Logistic regression model indicated that ≥7.45 Tg/HDL c ratio predicts requirement of invasive mechanical ventilation (OR 11.815, CI 1.832–76.186, p < 0.01). CONCLUSIONS: The Tg/HDLc ratio can be used as an early biochemical marker of COVID-19 severe prognosis with requirement of invasive mechanical ventilation. European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. 2021-08 2021-05-07 /pmc/articles/PMC8103772/ /pubmed/34330502 http://dx.doi.org/10.1016/j.clnesp.2021.04.020 Text en © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Alcántara-Alonso, Estefanía Molinar-Ramos, Fernando González-López, Jesús Alberto Alcántara-Alonso, Viridiana Muñoz-Pérez, Marco Antonio Lozano-Nuevo, José Juan Benítez-Maldonado, Daniel Rabindranath Mendoza-Portillo, Elizabeth High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title | High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title_full | High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title_fullStr | High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title_full_unstemmed | High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title_short | High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients |
title_sort | high triglyceride to hdl-cholesterol ratio as a biochemical marker of severe outcomes in covid-19 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103772/ https://www.ncbi.nlm.nih.gov/pubmed/34330502 http://dx.doi.org/10.1016/j.clnesp.2021.04.020 |
work_keys_str_mv | AT alcantaraalonsoestefania hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT molinarramosfernando hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT gonzalezlopezjesusalberto hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT alcantaraalonsoviridiana hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT munozperezmarcoantonio hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT lozanonuevojosejuan hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT benitezmaldonadodanielrabindranath hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients AT mendozaportilloelizabeth hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients |